BBIO's logo.
Ticker Symbol: BBIO

BridgeBio Pharma Inc

$47.25 - 04-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001743881

Company Profile

we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 421 Kipling St
CEO: Neil Kumar
Tags:
  • Health Technology
  • Pharmaceuticals: Generic
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $24.57
Change: -$0.11 ( -0.45%)
Days Range: $24.42 - $25.25
Beta: 2.07
52wk. High: $36.36
52wk. Low: $6.64
Ytd. Change 221.99%
50 Day Moving Average: $26.91
200 Day Moving Average: $22.25
Shares Outstanding: 162472000

Valuation

Market Cap: 399.2B
PE Ratio: -6.55
EPS (TTM): -3.75

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A